text
"['\nXII. 상세표\n1. 연결대상 종속회사 현황(상세)\n☞ 본문 위치로 이동\n(단위 : 백만원)\n상호\n설립일\n주소\n주요사업\n최근사업연도말자산총액\n지배관계 근거\n주요종속회사 여부\nTheravalues Corporation\n2007.04.25\n1st floor, Kioicho Building,3-12 Kioicho, Chiyoda-ku,Tokyo 102-0094, Japan\n기능성원료 개발 및 판매\n5,570\n지분율50% 초과보유\n-\nUnins(HK) International Limited(*1)\n1997.01.01\nUnit A 18th Floor, Public Bank Centre, No. 120 Des Voeux Road Central, HK\n의약품 판매\n142\n지분율50% 초과 보유\n-\n(주)이노큐브\n2021.09.09\n서울특별시 \xa0강남구 테헤란로 132\n창업인큐베이팅\n200\n지분율50% 초과 보유\n-\n(*1) Unins(H.K.) International Limited는 3월 결산법인으로 최근사업연도 재무현황은 2022년 3월 31일 기준으로 기재하였습니다.\n2. 계열회사 현황(상세)\n☞ 본문 위치로 이동\n(기준일 :\xa0\n2022년 06월 30일\n)\n(단위 : 사)\n상장여부\n회사수\n기업명\n법인등록번호\n상장\n3\n(주)한독\n110111-0037005\n(주)제넥신\n171711-0036705\n*Rezolute, Inc.\n27-3440894\n비상장\n6\n(주)칼로스메디칼\xa0\n110111-5849893\n(주)한독테바\xa0\n110111-5072733\n(주)엔비포스텍\n110111-3837311\n(주)이노큐브\n110111-8021125\nTheravalues Corporation\n5010001111641\n**Unins(HK) International Limited\n538470\n*법인등록번호의 경우 현지 Tax ID 입니다.**법인등록번호의 경우 현지 사업자 번호 입니다.\n3. 타법인출자 현황(상세)\n☞ 본문 위치로 이동\n(기준일 :\xa0\n2022년 06월 30일\n)\n(단위 : 백만원, 주, %)\n법인명\n상장여부\n최초취득일자\n출자목적\n최초취득금액\n기초잔액\n증가(감소)\n기말잔액\n최근사업연도재무현황\n수량\n지분율\n장부가액\n취득(처분)\n평가손익\n수량\n지분율\n장부가액\n총자산\n당기순손익\n수량\n금액\nUnins(H.K.) International Limited(*1)\n비상장\n1997.01.01\n경영참여\n549\n4,638,000\n100.00\n159\n-\n-\n-\n4,638,000\n100.00\n159\n142\n-1\n(주)한독테바\n비상장\n2013.02.21\n경영참여\n7,350\n15,680\n49.00\n23,520\n-\n-\n-\n15,680\n49.00\n23,520\n23,179\n854\n(주)제넥신\n상장\n2013.10.26\n경영참여\n29,021\n3,781,017\n15.11\n51,859\n-\n-\n-\n3,781,017\n15.11\n51,859\n639,926\n-44,003\n(주)칼로스메디칼(*2)\n비상장\n2015.10.01\n경영참여\n1,017\n178,862\n49.96\n996\n-\n-\n-\n178,862\n49.96\n996\n3,018\n-7,334\n㈜엔비포스텍\n비상장\n2016.03.14\n경영참여\n8,400\n1,100,010\n34.99\n6,437\n-\n-\n-\n1,100,010\n34.99\n6,437\n4,659\n438\nRezolute, INC.(*3)\n상장\n2019.01.28\n경영참여\n13,964\n2,784,722\n17.90\n35,890\n-\n-\n-\n2,784,722\n17.90\n35,890\n11,930\n-23,994\nTheravalues Corporation\xa0\n비상장\n2016.12.12\n경영참여\n21,304\n1,750,000\n100.00\n17,181\n-\n-\n-\n1,750,000\n100.00\n17,181\n5,570\n1,071\nMac Fund, L.P.(*4)\n비상장\n2013.01.08\n단순투자\n1,064\n-\n10.36\n976\n-\n-\n-\n-\n10.36\n976\n11,498\n899\nRMGP Bio-Pharma Investment Fund L.P\n비상장\n2017.04.28\n단순투자\n4,780\n-\n18.86\n5,295\n-\n745\n-\n-\n18.86\n6,040\n29,402\n-9,246\nHD Medical, Inc.(*5)\n비상장\n2017.06.28\n일반투자\n568\n188,844\n3.16\n568\n-\n-\n-\n188,844\n3.16\n568\n393\n-896\nSANA Health. INC.\n비상장\n2018.08.24\n일반투자\n281\n118,021\n1.05\n281\n-\n-\n-\n118,021\n1.05\n281\n5,272\n-6,472\nBiomX Ltd.\n상장\n2018.11.16\n일반투자\n2,929\n399,399\n1.43\n757\n-\n-\n\xa0 -380\n399,399\n1.43\n377\n92,457\n-41,458\nSCM생명과학㈜\n상장\n2019.05.24\n일반투자\n4,000\n141,048\n1.17\n2,743\n-\n-\n-1,371\n141,048\n1.17\n1,372\n54,045\n-22,519\nAdicet Bio, Inc.\n상장\n2019.07.25\n일반투자\n3,534\n290,454\n0.74\n6,022\n-\n-\n\xa0-539\n290,454\n0.74\n5,483\n401,811\n-70,953\n인터베스트오픈 이노베이션 사모투자합작회사\n비상장\n2020.12.30\n단순투자\n1,500\n\xa0 \xa0 \xa0 \xa0 \xa0 -\n\xa0 \xa06.25\n\xa0 6,000\n-\n1,500\n-\n-\n6.25\n\xa0 \xa0 \xa0 7,500\n93,474\n-3,740\n웰트(주)\n비상장\n2021.03.24\n일반투자\n\xa03,001\n\xa0 \xa0 5,486\n\xa0 \xa0 10\n\xa0 3,001\n-\n-\n-\n5,486\n9.94\n3,001\n11,141\n-1,446\nCompass Therapeutics, Inc.\n상장\n2021.06.24\n일반투자\n\xa09,094\n2,032,269\n\xa0 \xa0 \xa0 \xa03\n\xa0 7,637\n-\n-\n-674\n2,032,269\n3.30\n\xa0 \xa0 \xa06,963\n182,279\n-94,050\n(주)이노큐브\n비상장\n2021.09.07\n경영참여\n\xa0 200\n\xa0 \xa020,000\n\xa0 \xa0100\n\xa0 \xa0 \xa0200\n10,857\n\xa0 3,780\n-\n30,857\n72.97\n\xa0 \xa0 \xa03,980\n200\n-91\n스파크바이오파마(주)\n비상장\n2021.11.26\n일반투자\n3,000\n\xa0 \xa0 46,512\n\xa0 \xa0 \xa0 \xa0 2\n\xa0 3,000\n-\n-\n-\n46,512\n2.30\n\xa0 \xa0 \xa03,000\n15,166\n-10,075\nImmPACT Bio USA Inc.\n비상장\n2022.01.24\n일반투자\n1,319\n-\n-\n-\n70,479\n\xa01,319\n-\n70,479\n0.55\n\xa0 \xa0 \xa01,319\n-\n-\n합 계\n-\n-\n172,522\n-\n7,344\n-2,964\n-\n-\n176,902\n-\n-\n※ 피출자법인의 최근사업연도 총자산 및 당기순손익은 최근사업연도 기말잔액 및 실적을 기재하였습니다.(*1) Unins(H.K.) International Limited는 3월 결산법인으로 최근사업연도 재무현황은 2022년 3월 31일 기준으로 기재하였습니다.\n(*2) (주)칼로스메디칼 지분율의 경우 우선주를 제외한 비율입니다.(*3) Rezolute, Inc.는 6월 결산법인으로 최근사업연도 재무현황은 2021년 6월 30일 기준으로 기재하였습니다.(*4) Mac Fund, L.P.는 청산 절차 진행 중에 있습니다.(*5) HD Medical, Inc.의 경우 최근 사업연도 기말잔액 및 실적 확보가 어려워 확보 가능한 가장 최근의 자료를 기재하였습니다.\n4. 매출실적(상세)\n☞ 본문 위치로 이동\n가. 매출실적\n(단위 : 백만원)\n사업부문\n매출유형\n품 목\n제65기 2분기\n제64기\n제63기\n의약품제조및판매업\n제 \xa0품\n* 케토톱 群\xa0\n내수\n25,308\n45,041\n40,279\n수출\n745\n850\n910\n계\n26,053\n45,891\n41,189\n** 테넬리아 群\xa0\n내수\n24,597\n44,671\n38,430\n수출\n-\xa0\n-\xa0\n-\xa0\n계\n24,597\n44,671\n38,430\n*** 아마릴 群\n내수\n17,142\n33,318\n32,495\n수출\n6,004\n8,182\n13,576\n계\n23,146\n41,500\n46,071\n**** 훼스탈 群\n내수\n7,300\n13,808\n11,740\n수출\n-\xa0\n-\xa0\n-\xa0\n계\n7,300\n13,808\n11,740\n***** 트리테이스 群\n내수\n2,620\n5,816\n5,947\n수출\n-\xa0\n-\xa0\n-\xa0\n계\n2,620\n5,816\n5,947\n****** 테베텐 群\n내수\n1,666\n3,823\n4,290\n수출\n-\xa0\n-\xa0\n-\xa0\n계\n1,666\n3,823\n4,290\n기타\n내수\n29,794\n40,302\n42,009\n수출\n315\n716\n998\n계\n30,109\n41,018\n43,007\n합 계\n내수\n108,427\n186,779\n175,190\n수출\n7,064\n9,748\n15,484\n합계\n115,491\n196,527\n190,674\n상 \xa0품\n울토미리스\n내수\n17,906\n18,521\n-\xa0\n수출\n-\xa0\n-\xa0\n-\xa0\n계\n17,906\n18,521\n-\xa0\n솔리리스\n내수\n7,558\n32,938\n41,957\n수출\n-\xa0\n-\xa0\n-\xa0\n계\n7,558\n32,938\n41,957\n스틸녹스\n내수\n6,054\n11,638\n11,389\n수출\n-\xa0\n-\xa0\n-\xa0\n계\n6,054\n11,638\n11,389\n자트랄\n내수\n4,836\n9,285\n8,925\n수출\n-\xa0\n-\xa0\n-\xa0\n계\n4,836\n9,285\n8,925\n트리렙탈\n내수\n4,347\n8,800\n8,950\n수출\n-\xa0\n-\xa0\n-\xa0\n계\n4,347\n8,800\n8,950\n본비바\n내수\n3,826\n8,642\n10,780\n수출\n-\xa0\n-\xa0\n-\xa0\n계\n3,826\n8,642\n10,780\n기타\n내수\n34,905\n\xa0109,437\n\xa0108,103\n수출\n-\xa0\n75\n-\xa0\n계\n34,905\n109,512\n\xa0108,103\n합 계\n내수\n79,432\n199,261\n190,104\n수출\n-\xa0\n75\n-\xa0\n합계\n79,432\n199,336\n190,104\n시약 및 의료기기\n상품\n내수\n41,080\n76,739\n77,649\n수출\n-\xa0\n244\n-\xa0\n합계\n41,080\n76,983\n77,649\n컨슈머헬스\n상품\n내수\n253\n2,508\n683\n제품\n내수\n2,553\n4,207\n7,235\n제품\n수출\n228\n861\n464\n합계\n3,034\n7,576\n8,382\n기타\n용역\n용역수익\n내수\n13,682\n26,776\n26,507\n임대\n건물임대\n내수\n1,996\n3,950\n3,912\n총 \xa0계\n254,715\n511,148\n497,228\n※ 상기 실적은 별도기준입니다.* 케토톱플라스타, 케토톱엘플라스타, 케토톱겔이 포함되어 있습니다.** 테넬리아, 테넬리아엠이 포함되어 있습니다.*** 아마릴, 아마릴엠, 아마릴 멕스, 아마릴SR이 포함되어 있습니다.**** 훼스탈골드, 훼스탈플러스가 포함되어 있습니다.***** 트리테이스, 트리테이스 프로텍트, 트리테이스 플러스가 포함되어 있습니다.****** 테베텐, 테베텐 플러스가 포함되어 있습니다.\n5. 지적재산권 보유현황(상세)\n☞ 본문 위치로 이동\n구분\n종류\n취득일\n명칭\n등록번호\n독점적사용기간\n제품화여부 \xa0및 연구단계\n제품의 명칭\n특허\n조성물\n2007-04-02\n경구투여를 위한 당뇨병 치료용 약제학적 복합제제\nKR0705210\n(한국) 2025-09-22\n제품화\n아마릴MEX\n특허\n조성물\n2007-04-20\n서방성 제제 및 그의 제조방법\nKR0712356\n(한국) 2024-01-19\n연구단계\n-\n특허\n방법\n2011-03-03\n유전자 PNRC2를 이용한 NMD 조절 방법\nKR1021402\n(한국) 2028-05-08\n연구단계\n-\n특허\n조성물\n2012-01-11\n반투과성 막에 수용성 활성성분을 포함하는 서방형 약제학적 조성물\nKR1107432\n(한국) 2028-04-14\n연구단계\n-\n특허\n제조방법\n2012-11-01\n구형의 판크레아틴 과립의 제조방법\nKR1199196\n(한국) 2025-07-25\n연구단계\n-\n특허\n조성물\n2015-06-01\n당뇨병 치료용 약제학적 조성물\nKR1526825\n(한국)2034-12-23\n제품화\n테넬리아M\n특허\n조성물\n2006-12-222014-05-202017-06-142012-10-03\n소수성 비스테로이드성 소염진통제를 함유하는 경피 투여 제제\nKR663163 US8728514 EP1951211 CN101370487\n(한국) 2025-10-24 (미국) 2029-09-04 (유럽) 2026-10-23 (중국) 2026-10-23\n제품화\n케토톱\n특허\n물질\n2013-11-272014-11-11\n인간 인터루킨-1 수용체 길항제-하이브리드 Fc 융합단백질\nKR1333958 US8883134\n(한국) 2031-10-19 (미국) 2031-10-19\n연구단계\n-\n특허\n조성물\n2014-08-012015-06-19\n아리피프라졸 함유 구강 붕해 정제 및 이의 제조 방법\nKR1428018 JP5764688\n(한국) 2034-02-28 (일본) 2034-04-01\n연구단계\n-\n특허\n물질\n2014-12-082016-04-262016-04-20\n신규한 베타 알라닌 유도체, 약학적으로 허용가능한 염 및 이를 유효성분으로 함유하는 약제학적 조성물\nKR1472279 US9321728 CN104254519\n(한국) 2033-04-25 (미국) 2033-04-25 (중국) 2033-04-25\n연구단계\n-\n특허\n물질\n2017-06-02\n신규한 트리아졸로 피라진 유도체 및 그의 용도\nKR1745741\n(한국) 2032-08-13\n연구단계\n-\n특허\n물질\n2017-07-11\nFUSED RING HETEROARYL COMPOUNDS AND THEIR USE AS TRK INHIBITORS\nUS9701681\n(미국) 2035-12-14\n연구단계\n-\n특허\n조성물\n2017-09-20\n테넬리글립틴 및 설포닐우레아계 약물을 포함하는 정제\nKR1782119\n(한국)2036-02-01\n연구단계\n-\n특허\n물질\n2018-03-21\n신규한 히드라진온이 치환된 피리미딘 유도체 및 그의 용도\nKR1842645\n(한국) 2032-04-12\n연구단계\n-\n특허\n물질\n2018-06-14\n신규한 트리아졸로 피리다진 유도체 및 그의 용도\nKR1869534\n(한국) 2032-03-05\n연구단계\n-\n특허\n물질\n2019-02-05\nCompounds antagonizing A3 adenosine receptor, method for preparing them, and medical-use thereof\nUS 10196396\n(미국) 2037-01-13\n연구단계\n-\n특허\n조성물\n2019-03-26\n피부 자극이 감소된 메만틴 경피전달 시스템\nKR 1964295\n(한국) 2032-09-05\n연구단계\n-\n특허\n물질\n2019-11-01\nFUSED RING HETEROARYL COMPOUNDS AND THEIR USE AS TRK INHIBITORS\nJP 6609631\n(일본) 2035-12-14\n연구단계\n-\n특허\n물질\n2019-12-11\nFUSED RING HETEROARYL COMPOUNDS AND THEIR USE AS TRK INHIBITORS\nRU 2708674\n(러시아) 2035-12-14\n연구단계\n-\n특허\n물질\n2020-01-24\nFUSED RING HETEROARYL COMPOUNDS AND THEIR USE AS TRK INHIBITORS\nCN ZL201580075880.1\n(중국) 2035-12-14\n연구단계\n-\n특허\n물질\n2020-02-17\nFUSED RING HETEROARYL COMPOUNDS AND THEIR USE AS TRK INHIBITORS\nIN IDP000067410\xa0\n(인도) 2035-12-14\n연구단계\n-\n특허\n조성물\n2020-06-30\n당뇨병 치료용 약제학적 조성물\nCN ZL201580070627.7\n(중국) 2035-12-22\n제품화\n테넬리아M\n특허\n조성물\n2020-07-23\n당뇨병 치료용 약제학적 조성물\nSG 11201705194X\n(싱가포르) 2035-12-22\n제품화\n테넬리아M\n특허\n조성물\n2020-09-11\nhGH 융합단백질을 포함하는 성장호르몬 결핍을 치료하기 위한 약학 조성물\nRU 2732113\n(러시아) 2037-02-16\n연구단계\nGX-H9\n특허\n물질\n2020-11-05\nFUSED RING HETEROARYL COMPOUNDS AND THEIR USE AS TRK INHIBITORS\nAU 2015365587\n(호주) 2035-12-14\n연구단계\n-\n특허\n물질\n2020-11-25\nCompounds antagonizing A3 adenosine receptor, method for preparing them, and medical-use thereof\n\xa0RU 2737157\n(러시아) 2037-01-13\n연구단계\n-\n특허\n물질\n2021-01-15\nFUSED RING HETEROARYL COMPOUNDS AND THEIR USE AS TRK INHIBITORS\nHK1242314\n(홍콩) 2035-12-14\n연구단계\n\u3000\n특허\n조성물\n2021-01-29\n당뇨병 치료용 약제학적 조성물\nHK1239530\n(홍콩) 2035-12-22\n제품화\n테넬리아M\n특허\n용량용법\n2021-02-11\nhGH 융합단백질을 포함하는 성장호르몬 결핍을 치료하기 위한 약학 조성물\nTW I718334\n(대만) 2037-08-29\n연구단계\nGX-H9\n특허\n용량용법\n2021-06-11\nhGH 융합단백질을 포함하는 성장호르몬 결핍을 치료하기 위한 약학 조성물\nJP 6896749\n(일본) 2037-02-16\n연구단계\nGX-H9\n특허\n용량용법\n2021-07-01\nhGH 융합단백질을 포함하는 성장호르몬 결핍을 치료하기 위한 약학 조성물\nTW I732713\n(대만) 2037-08-29\n연구단계\nGX-H9\n특허\n용량용법\n2021-09-30\nhGH 융합단백질을 포함하는 성장호르몬 결핍을 치료하기 위한 약학 조성물\nKR 10-2309668\n(한국) 2037-08-30\xa0\n연구단계\nGX-H9\n특허\n조성물\n2021-09-09\nPHARMACEUTICAL COMPOSITION FOR TREATING DIABETES AND PREPARATION METHOD THEREFOR\n29741\n(베트남) 2035-12-22\n제품화\n테넬리아M\n특허\n용량용법\n2021-10-07\nhGH 융합단백질을 포함하는 성장호르몬 결핍을 치료하기 위한 약학 조성물\nKR 10-2312986\n(한국) 2037-02-16\n연구단계\nGX-H9\n특허\n조성물\n2021-10-08\n커큐민을 함유하는 숙취해소용 제제\nKR 10-2313511\n(한국) 2034-04-04\n제품화\n레디큐\n특허\n용량용법\n2021-10-22\n당뇨병 치료용 약제학적 조성물\n\xa0IDP000079487\n(인도네시아) 2035-10-22\n제품화\n테넬리아M\n특허\n용량용법\n2022-03-16\nhGH 융합단백질을 포함하는 성장호르몬 결핍을 치료하기 위한 약학 조성물\n3885\n(요르단) 2037-02-16\n연구단계\nGX-H9\n특허\n용량용법\n2022-07-07\nhGH 융합단백질을 포함하는 성장호르몬 결핍을 치료하기 위한 약학 조성물\n3416677\n(유럽) 2037-02-16\n연구단계\nGX-H9\n특허\n용량용법\n발급중\nhGH 융합단백질을 포함하는 성장호르몬 결핍을 치료하기 위한 약학 조성물\n발급중\n(중국) 발급중\n연구단계\nGX-H9\n상표\n국문상표\n1988-08-25\n한독\n40-0158523\n(한국) 2028-08-25\n제품화\n사명\n상표\n국문/영문상표\n1988-08-25\n한독 HANDOK\n40-0158524\n(한국) 2028-08-25\n제품화\n사명\n상표\n국문상표\n1990-07-03\n다이어트라\n40-0195373\n(한국) 2030-07-03\n제품화\n다이어트라\n상표\n영문상표\n1990-07-03\nDIETRA\n40-0195374\n(한국) 2030-07-03\n제품화\n다이어트라\n상표\n국문상표\n1993-12-22\n하이비날\n40-0282189\n(한국) 2023-12-22\n제품화\n하이비날\n상표\n영문상표\n1993-12-22\nHIVINAL\n40-0282190\n(한국) 2023-12-22\n제품화\n하이비날\n상표\n국문상표\n1993-12-22\n하이렉스\n40-0282191\n(한국) 2023-12-22\n제품화\n하이비날\n상표\n영문상표\n1993-12-22\nHILEX\n40-0282192\n(한국) 2023-12-22\n제품화\n하이비날\n상표\n국문상표\n1994-05-13\n한독\n41-0023792\n(한국) 2024-05-13\n제품화\n사명\n상표\n영문상표\n1994-05-13\nHANDOK\n41-0023793\n(한국) 2024-05-13\n제품화\n사명\n상표\n국문상표\n1994-05-13\n한독\n41-0023792\n(한국) 2024-05-13\n제품화\n사명\n상표\n영문상표\n1994-05-13\nHANDOK\n41-0023793\n(한국) 2024-05-13\n제품화\n사명\n상표\n국문/영문상표\n1995-05-02\n케토톱플라스타KETOTOPPLASTER\n40-0312566\n(한국) 2025-05-02\n제품화\n케토톱\n상표\n국문상표\n1995-09-01\n타리겐\n40-0321252\n(한국) 2025-09-01\n제품화\n타리겐\n상표\n국문상표\n1995-11-29\n브롬콜\n40-0328069\n(한국) 2025-11-29\n제품화\n브롬콜\n상표\n영문상표\n1996-04-18\nKETOTOP\n40-0337331\n(한국) 2026-04-18\n제품화\n케토톱\n상표\n영문상표\n1996-09-11\nHANDOK\n40-0346730\n(한국) 2026-09-11\n제품화\n사명\n상표\n영문상표\n1996-09-30\nHANDOK\n40-0347665\n(한국) 2026-09-30\n제품화\n사명\n상표\n중문상표\n1996-12-15\nKETOTOP\n739313\xa0\n(대만) 2026-12-14\n제품화\n케토톱\n상표\n영문상표\n1997-02-21\nKETOTOP\n948696\xa0\n(중국) 2027-02-20\n제품화\n케토톱\n상표\n국문/영문상표\n1997-02-26\n한독 HANDOK\n40-0357023\n(한국) 2027-02-28\n제품화\n사명\n상표\n영문상표\n1997-02-26\nHANDOK\n40-0357024\n(한국) 2027-02-28\n제품화\n사명\n상표\n영문상표\n1997-02-26\nHANDOK\n40-0357025\n(한국) 2027-02-28\n제품화\n사명\n상표\n영문상표\n1997-02-28\nHANDOK\n41-0035158\n(한국) 2027-02-28\n제품화\n사명\n상표\n영문상표\n1997-02-28\nHANDOK\n41-0035157\n(한국) 2027-02-28\n제품화\n사명\n상표\n영문상표\n1997-02-28\nHANDOK\n41-0035156\n(한국) 2027-02-28\n제품화\n사명\n상표\n국문/영문상표\n1997-02-28\n한독 HANDOK\n41-0035155\n(한국) 2027-02-28\n제품화\n사명\n상표\n영문상표\n1997-02-28\nHANDOK\n41-0035159\n(한국) 2027-02-28\n제품화\n사명\n상표\n영문상표\n1997-02-28\nHANDOK\n41-0035161\n(한국) 2027-02-28\n제품화\n사명\n상표\n영문상표\n1997-02-28\nHANDOK\n41-0035160\n(한국) 2027-02-28\n제품화\n사명\n상표\n국문/영문상표\n1997-02-28\n한독 HANDOK\n41-0035151\n(한국) 2027-02-28\n제품화\n사명\n상표\n국문/영문상표\n1997-02-28\n한독 HANDOK\n41-0035150\n(한국) 2027-02-28\n제품화\n사명\n상표\n국문/영문상표\n1997-02-28\n한독 HANDOK\n41-0035154\n(한국) 2027-02-28\n제품화\n사명\n상표\n국문/영문상표\n1997-02-28\n한독 HANDOK\n41-0035152\n(한국) 2027-02-28\n제품화\n사명\n상표\n국문/영문상표\n1997-02-28\n한독 HANDOK\n41-0035153\n(한국) 2027-02-28\n제품화\n사명\n상표\n국문상표\n1997-03-26\n바크로비\n40-0143612\n(한국) 2027-07-29\n제품화\n바크로비\n상표\n영문상표\n1997-07-22\nHANDOK\n41-0037405\n(한국) 2027-07-22\n제품화\n사명\n상표\n영문상표\n1997-08-21\nVACROVIR\n40-0372898\n(한국) 2027-08-21\n제품화\n바크로비\n상표\n도형상표\n1997-09-26\n도형상표(1997.09.26)\n40-0376222\n(한국) 2027-09-26\n제품화\n케토톱\n상표\n국문상표\n1998-01-21\n한독\n40-0392128\n(한국) 2028-01-21\n제품화\n사명\n상표\n영문상표\n1998-01-21\nHANDOK\n40-0392129\n(한국) 2028-01-21\n제품화\n사명\n상표\n국문상표\n1998-03-04\n토토톱\n40-0398265\n(한국) 2028-03-04\n제품화\n케토톱\n상표\n국문상표\n1998-03-04\n케로톱\n40-0398267\n(한국) 2028-03-04\n제품화\n케토톱\n상표\n도형상표\n1998-06-24\n도형상표(1998.06.24)\n40-0406203\n(한국) 2028-06-24\n제품화\n케토톱\n상표\n중문상표\n1998-07-07\n基多托\n948696\xa0\n(중국) 2027-02-20\n제품화\n케토톱\n상표\n국문상표\n1998-07-29\n케토킹\n40-0413219\n(한국) 2028-07-29\n제품화\n케토톱\n상표\n영문상표\n1998-08-08\nHomeDoctor\n40-0415036\n(한국) 2028-08-08\n제품화\n홈닥터\n상표\n국문상표\n1998-08-08\n홈닥터\n40-0415037\n(한국) 2028-08-08\n제품화\n홈닥터\n상표\n영문상표\n1999-02-01\nWINSTALFORTE\n40-0440334\n(한국) 2029-02-01\n-\n-\n상표\n영문상표\n1999-06-15\nKETOTOP\nT9607363G\n(싱가폴) 2026-07-18\n제품화\n케토톱\n상표\n영문상표\n2000-04-24\nKETOTOP\n162418\xa0\n(파키스탄) 2030-04-24\n제품화\n케토톱\n상표\n영문상표\n2000-06-23\nKETOTOP\n4395071\xa0\n(일본) 2030-06-23\n제품화\n케토톱\n상표\n영문상표\n2000-08-08\nKETOTOP EL\n40-0474883\n(한국) 2030-08-08\n제품화\n케토톱\n상표\n국문/영문상표\n2001-07-04\n한독 HANDOK\n40-0496955\n(한국) 2021-07-04\n제품화\n사명\n상표\n국문/영문상표\n2001-07-06\n엠펜M.PAN\n40-0497130\n(한국) 2021-07-06\n-\n-\n상표\n국문/영문상표\n2001-07-10\n다이어트라 DIETRA\n40-0207069\n(한국) 2021-07-10\n-\n-\n상표\n영문상표\n2002-04-25\nHavisco\n40-0518665\n(한국) 2022-04-25\n-\n-\n상표\n영문상표\n2002-05-30\nBromcol\n40-0521758\n(한국) 2022-05-30\n-\n-\n상표\n국문상표\n2002-05-30\n브롬콜 플러스\n40-0521755\n(한국) 2022-05-30\n제품화\n브롬콜\n상표\n국문상표\n2002-05-30\n브롬콜 엔\n40-0521756\n(한국) 2022-05-30\n제품화\n브롬콜\n상표\n국문상표\n2002-05-30\n브롬콜 코프\n40-0521757\n(한국) 2022-05-30\n제품화\n브롬콜\n상표\n국문상표\n2003-11-20\n레프록사신\n40-0566086\n(한국) 2023-11-20\n제품화\n레프록사신\n상표\n국문상표\n2003-12-05\n래리스\n40-0567796\n(한국) 2023-12-05\n-\n-\n상표\n영문상표\n2003-12-05\nLarith\n40-0567797\n(한국) 2023-12-05\n-\n-\n상표\n도형상표\n2004-02-05\n도형상표(2004.02.05)\n40-0573603\n(한국) 2024-02-05\n제품화\n브롬콜\n상표\n영문상표\n2004-03-18\nKontram XL\n40-0577875\n(한국) 2024-03-18\n-\n-\n상표\n영문상표\n2004-03-18\nLipidatin\n40-0577877\n(한국) 2024-03-18\n-\n-\n상표\n영문상표\n2004-03-18\nPzocin\n40-0577878\n(한국) 2024-03-18\n-\n-\n상표\n영문상표\n2004-03-18\nVedilol\n40-0577879\n(한국) 2024-03-18\n-\n-\n상표\n영문상표\n2004-03-18\nKontram XL\n40-0577875\n(한국) 2024-03-18\n-\n-\n상표\n영문상표\n2004-03-18\nLipidatin\n40-0577877\n(한국) 2024-03-18\n-\n-\n상표\n영문상표\n2004-03-18\nPzocin\n40-0577878\n(한국) 2024-03-18\n-\n-\n상표\n영문상표\n2004-03-18\nVedilol\n40-0577879\n(한국) 2024-03-18\n-\n-\n상표\n영문상표\n2004-04-20\nKETOTOP\n2833722\xa0\n(미국) 2030-04-20\n제품화\n케토톱\n상표\n영문상표\n2004-08-18\nAcamend\n40-0590422\n(한국) 2024-08-18\n-\n-\n상표\n국문/영문상표\n2004-08-18\n멜콕스Melcox\n40-0590423\n(한국) 2024-08-18\n제품화\n멜콕스\n상표\n영문상표\n2004-08-18\nFuconax\n40-0590424\n(한국) 2024-08-18\n-\n-\n상표\n영문상표\n2004-09-07\nErstant\n40-0592594\n(한국) 2024-09-07\n-\n-\n상표\n영문상표\n2004-10-16\nRUFLOXIN\n40-0596145\n(한국) 2024-10-16\n제품화\n루플록신\n상표\n국문상표\n2004-10-16\n루플록신\n40-0596144\n(한국) 2024-10-16\n제품화\n루플록신\n상표\n국문상표\n2004-11-08\n케토톱 플라스타\n40-0598515\n(한국) 2024-11-08\n제품화\n케토톱\n상표\n영문상표\n2004-11-22\nTrompirin\n40-0600128\n(한국) 2024-11-22\n-\n-\n상표\n영문상표\n2005-02-14\nTARIGEN\n40-0608398\n(한국) 2025-02-14\n제품화\n타리겐\n상표\n국문상표\n2005-02-14\n콘트람엑스엘\n40-0608399\n(한국) 2025-02-14\n-\n-\n상표\n영문상표\n2005-04-04\nTalosin\n40-0613528\n(한국) 2025-04-04\n-\n-\n상표\n영문상표\n2005-04-21\nAcepic\n40-0615315\n(한국) 2025-04-21\n-\n-\n상표\n영문상표\n2005-06-10\nPengatin\n40-0620902\n(한국) 2025-06-10\n-\n-\n상표\n영문상표\n2005-06-20\nKETOTOP\n96007590\xa0\n(말레이시아) 2023-07-10\n제품화\n케토톱\n상표\n국문/영문상표\n2006-01-05\n피나이스Finice\n40-0646066\n(한국) 2026-01-05\n-\n-\n상표\n국문/영문상표\n2006-02-28\n당뇨Cody\n41-0128620\n(한국) 2026-02-28\n제품화\n당뇨코디\n상표\n국문상표\n2006-02-28\n당뇨코디\n41-0128618\n(한국) 2026-02-28\n제품화\n당뇨코디\n상표\n영문상표\n2006-06-02\nSULOSIN\n40-0664825\n(한국) 2026-06-02\n제품화\n수로신\n상표\n영문상표\n2007-03-13\nKETOTOP\n40-0701715\n(한국) 2027-03-13\n제품화\n케토톱\n상표\n영문상표\n2008-03-03\nKETOTOP\nIDM000156573\n(인도네시아) 2026-08-02\n제품화\n케토톱\n상표\n국문/영문상표\n2008-09-12\n엑스페인X-PAIN\n40-0760950\n(한국) 2028-09-12\n제품화\n엑스페인\n상표\n국문/영문상표\n2009-01-23\n한독 HANDOK\n40-0421831\n(한국) 2028-09-18\n제품화\n사명\n상표\n국문/영문상표\n2009-06-04\n헬스토피아 Healthtopia\n40-0406142\n(한국) 2028-06-24\n-\n-\n상표\n국문상표\n2010-03-12\n팍세론틴\n40-0816824\n(한국) 2030-03-12\n제품화\n팍세론틴\n상표\n국문/영문상표\n2010-05-10\n올데사르OLDESAR\n40-0822573\n(한국) 2030-05-10\n-\n-\n상표\n영문상표\n2010-06-01\nHYDUET\n40-0824778\n(한국) 2030-06-01\n-\n-\n상표\n국문/영문상표\n2011-01-03\n헵토리버HEPTOLIVER\n40-0848328\n(한국) 2031-01-03\n-\n-\n상표\n영문상표\n2011-03-02\nBAROZeN\n40-0855266\n(한국) 2031-03-02\n제품화\n바로잰\n상표\n국문상표\n2011-06-13\n한독 코디플러스\n41-0211712\n(한국) 2031-06-13\n제품화\n코디플러스\n상표\n국문상표\n2011-06-13\n코디플러스\n41-0211686\n(한국) 2031-06-13\n제품화\n코디플러스\n상표\n영문상표\n2011-06-13\nHandok Cody-Plus\n41-0211720\n(한국) 2031-06-13\n제품화\n코디플러스\n상표\n국문상표\n2011-11-21\n네이처셋\n40-0890803\n(한국) 2031-11-21\n제품화\n네이처셋\n상표\n국문/영문상표\n2011-11-21\n바로잰 HAN DOK\n40-0890802\n(한국) 2031-11-21\n제품화\n바로잰\n상표\n국문/영문상표\n2011-12-15\n쎄렉스CELEX\n40-0894620\n(한국) 2031-12-15\n제품화\n쎄렉스\n상표\n영문상표\n2012-01-27\nN NatureSet\n40-0901067\n(한국) 2022-01-27\n제품화\n네이처셋\n상표\n영문상표\n2012-01-27\nN NatureSet\n40-0901065\n(한국) 2022-01-27\n제품화\n네이처셋\n상표\n영문상표\n2012-01-27\nN NatureSet\n40-0901064\n(한국) 2022-01-27\n제품화\n네이처셋\n상표\n국문상표\n2012-02-23\n훼스탈과 함께하는 식후 30분 콘서트\n41-0227109\n(한국) 2022-02-23\n제품화\n훼스탈\n상표\n영문상표\n2012-02-23\nN NatureSet\n40-0906239\n(한국) 2022-02-23\n제품화\n네이처셋\n상표\n국문상표\n2012-03-06\n리마노스\n40-0908432\n(한국) 2022-03-06\n-\n-\n상표\n국문상표\n2012-03-15\n에스렉스\n40-0910378\n(한국) 2022-03-15\n-\n-\n상표\n국문상표\n2012-03-15\n가베트\n40-0910377\n(한국) 2022-03-15\n제품화\n가베트\n상표\n영문상표\n2012-07-30\nSDN Scientist-Designed Nutrition\n40-0928758\n(한국) 2022-07-30\n제품화\n네이처셋\n상표\n영문상표\n2012-07-30\nSDN Scientist-Designed Nutrition\n40-0928757\n(한국) 2022-07-30\n제품화\n네이처셋\n상표\n영문상표\n2012-09-18\nN NatureSet\n40-0934588\n(한국) 2022-09-18\n제품화\n네이처셋\n상표\n영문상표\n2012-11-07\nSDN Scientist-Designed Nutrition\n40-0940188\n(한국) 2022-11-07\n제품화\n네이처셋\n상표\n영문상표\n2012-11-07\nSDN Scientist-Designed Nutrition\n40-0940187\n(한국) 2022-11-07\n제품화\n네이처셋\n상표\n영문상표\n2012-12-06\nSDN Scientist-Designed Nutrition\n40-0943657\n(한국) 2022-12-06\n제품화\n네이처셋\n상표\n국문상표\n2013-02-14\n올리브올리\n40-0953413\n(한국) 2023-02-14\n제품화\n워너비\n상표\n국문상표\n2013-07-17\n워너비올리브\n40-0982806\n(한국) 2023-07-17\n제품화\n워너비올리브\n상표\n국문상표\n2013-07-17\n워너비스피드\n40-0982805\n(한국) 2023-07-17\n제품화\n워너비스피드\n상표\n국문상표\n2013-07-17\n워너비스트롱\n40-0982804\n(한국) 2023-07-17\n제품화\n워너비\n상표\n국문상표\n2013-07-17\n네이처셋 홍오메가3\n40-0982807\n(한국) 2023-07-17\n제품화\n홍오메가3\n상표\n국문상표\n2013-08-13\n이지포지\n40-0988346\n(한국) 2023-08-13\n제품화\n메가포지\n상표\n국문상표\n2013-08-13\n시너저원\n40-0988347\n(한국) 2023-08-13\n제품화\n메가포지\n상표\n국문상표\n2013-08-13\n듀오케이드\n40-0988345\n(한국) 2023-08-13\n제품화\n메가포지\n상표\n국문/영문상표\n2013-09-11\n레프록신LEFLOXIN\n40-0994479\n(한국) 2023-09-11\n제품화\n레프록신\n상표\n국문/영문상표\n2013-09-23\n한독 The Health Innovator\n40-0996251\n(한국) 2023-09-23\n제품화\n사명\n상표\n국문/영문상표\n2013-10-01\n덱사소론Dexasolone\n40-0999406\n(한국) 2023-10-01\n-\n-\n상표\n국문/영문상표\n2013-10-02\n스토티딘STOTIDINE\n40-0998519\n(한국) 2023-10-02\n-\n-\n상표\n국문상표\n2013-12-11\n네이처셋 홍오메가3\n41-0275309\n(한국) 2023-12-11\n제품화\n홍오메가3\n상표\n국문상표\n2013-12-16\n클리어틴\n40-1012956\n(한국) 2023-12-16\n제품화\n클리어틴\n상표\n영문상표\n2013-12-16\nCLEARTEEN\n40-1012981\n(한국) 2023-12-16\n제품화\n클리어틴\n상표\n국문상표\n2014-01-10\n네이처셋 홍오메가3\n41-0277487\n(한국) 2024-01-10\n제품화\n홍오메가3\n상표\n국문/영문상표\n2014-02-21\n약연탑 Yak Yon MOUNMENT\n41-0281058\n(한국) 2024-02-21\n-\n-\n상표\n국문/영문상표\n2014-02-21\n약연탑 Yak Yon MOUNMENT\n41-0281044\n(한국) 2024-02-21\n-\n-\n상표\n영문상표\n2014-02-21\nReadyQ\n40-1023954\n(한국) 2024-02-21\n제품화\n레디큐\n상표\n국문상표\n2014-02-26\n진케어\n41-0281398\n(한국) 2024-02-26\n제품화\n진케어\n상표\n국문/영문상표\n2014-03-13\nThe Health Innovator 한독\n41-0283097\n(한국) 2024-03-13\n제품화\n사명\n상표\n국문/영문상표\n2014-03-17\n리본느 REBONNE\n1028067\n(한국) 2024-03-17\n-\n-\n상표\n국문/영문상표\n2014-04-01\nThe Health Innovator 한독\n41-0284679\n(한국) 2024-04-01\n제품화\n사명\n상표\n영문상표\n2014-04-07\nGENECARE\n41-0285270\n(한국) 2024-04-07\n제품화\n진케어\n상표\n국문상표\n2014-05-08\n워너비\n40-1036179\n(한국) 2024-05-08\n제품화\n워너비\n상표\n국문상표\n2014-05-12\n테라커민\n40-1036782\n(한국) 2024-05-12\n제품화\n테라큐민\n상표\n국문상표\n2014-05-12\n테라큐민\n40-1036781\n(한국) 2024-05-12\n제품화\n테라큐민\n상표\n국문상표\n2014-05-20\n진케어\n40-1038316\n(한국) 2024-05-20\n제품화\n진케어\n상표\n국문상표\n2014-05-20\n진케어\n41-0288804\n(한국) 2024-05-20\n제품화\n진케어\n상표\n국문상표\n2014-05-23\n테라큐민\n40-1038916\n(한국) 2024-05-20\n제품화\n테라큐민\n상표\n국문상표\n2014-05-23\n테라큐민\n40-1038917\n(한국) 2024-05-23\n제품화\n테라큐민\n상표\n국문상표\n2014-05-29\n메가포지\n40-1039764\n(한국) 2024-05-29\n제품화\n메가포지\n상표\n영문상표\n2014-05-29\nReadyQ\n40-1039763\n(한국) 2024-05-29\n제품화\n레디큐\n상표\n영문상표\n2014-06-17\nReadyQ\n40-1043126\n(한국) 2024-06-17\n제품화\n레디큐\n상표\n국문상표\n2014-06-19\n레이디큐\n40-1043561\n(한국) 2024-06-19\n제품화\n레디큐\n상표\n국문상표\n2014-06-19\n레이디큐\n40-1043560\n(한국) 2024-06-19\n제품화\n레디큐\n상표\n국문상표\n2014-07-23\n진케어\n41-0294628\n(한국) 2024-07-23\n제품화\n진케어\n상표\n영문상표\n2014-07-23\nGENECARE\n41-0294627\n(한국) 2024-07-23\n제품화\n진케어\n상표\n영문상표\n2014-08-18\nReadyQ\n40-1054009\n(한국) 2024-08-18\n제품화\n레디큐\n상표\n국문상표\n2014-08-19\n테라큐민\n40-1054285\n(한국) 2024-08-19\n제품화\n테라큐민\n상표\n국문상표\n2014-09-29\n레이디큐\n40-1061115\n(한국) 2024-09-29\n제품화\n레디큐\n상표\n국문상표\n2014-12-24\n사랑플러스\n1077595\n(한국) 2024-12-24\n-\n-\n상표\n영문상표\n2015-01-04\nKETOTOP\n13609\xa0\n(키르기즈) 2025-02-04\n제품화\n케토톱\n상표\n영문상표\n2015-01-12\nKETOTOP\n271958\xa0\n(베트남) 2025-01-12\n제품화\n케토톱\n상표\n영문상표\n2015-01-13\nKETOTOP\n40201500724X\n(싱카폴) 2025-01-13\n제품화\n케토톱\n상표\n국문상표\n2015-03-05\n레디-큐\n1092022\n(한국) 2025-03-05\n제품화\n레디큐\n상표\n국문상표\n2015-04-15\n셀레타민\n1100383\n(한국) 2025-04-15\n제품화\n싸이타민\n상표\n국문상표\n2015-04-15\n싸이타민\n40-1100382\n(한국) 2025-04-15\n제품화\n싸이타민\n상표\n국문상표\n2015-04-24\n맛있는 숙취해소제 레디-큐\n40-1102088\n(한국) 2025-04-24\n제품화\n레디큐\n상표\n영문상표\n2015-06-03\nTheracurmin\n40-1109665\n(한국) 2025-06-03\n제품화\n테라큐민\n상표\n국문상표\n2015-09-08\n테넬리아로고\n40-1128805\n(한국) 2025-09-08\n제품화\n테넬리아\n상표\n국문상표\n2015-11-23\n로코젯\n40-1144537\n(한국) 2025-11-23\n제품화\n메가로젯\n상표\n국문상표\n2015-11-23\n하이로제\n40-1144538\n(한국) 2025-11-23\n제품화\n메가로젯\n상표\n국문상표\n2016-02-01\n스팟 톡\n40-1158112\n(한국) 2026-02-01\n제품화\n클리어틴\n상표\n국문상표\n2016-02-29\n메가로젯\n40-1163375\n(한국) 2026-02-28\n제품화\n메가로젯\n상표\n영문상표\n2016-04-11\nKETOTOP\n58191\xa0\n(벨라루스) 2025-02-03\n제품화\n케토톱\n상표\n영문상표\n2016-04-14\nKETOTOP\n12058\xa0\n(타지키스탄) 2025-02-05\n제품화\n케토톱\n상표\n영문상표\n2016-07-11\nKETOTOP\n213860\n(우크라이나) 2025-02-10\n제품화\n케토톱\n상표\n영문상표\n2016-09-02\nQ&A\n40-1200379\n(한국) 2026-09-02\n-\n-\n상표\n영문상표\n2016-09-23\nKETOTOP\n13801\n(투르크매니스탄) 2025-02-09\n제품화\n케토톱\n상표\n영문상표\n2016-10-05\nKETOTOP\n589745\xa0\n(러시아) 2025-01-30\n제품화\n케토톱\n상표\n입체상표\n2016-10-21\n레디큐 입체상표\n40-1210805\n(한국) 2026-10-21\n제품화\n레디큐\n상표\n영문상표\n2016-12-29\nKETOTOP\nMGU 30722\n(우즈베키스탄) 2026-05-04\n제품화\n케토톱\n상표\n영문상표\n2017-01-10\nReady Q\n40-1226576\n(한국) 2027-01-10\n제품화\n레디큐\n상표\n국문상표\n2017-01-10\n레디-큐\n40-1226577\n(한국) 2027-01-10\n제품화\n레디큐\n상표\n입체상표\n2017-01-10\n레디큐츄+도형\n40-1226581\n(한국) 2027-01-10\n제품화\n레디큐\n상표\n중문상표\n2017-02-28\n루이디쿠(한자)(서제혹)\n19007020\xa0\n(중국) 2027-02-27\n제품화\n레디큐\n상표\n중문상표\n2017-02-28\n르어닝쿠(한자)(락저혹)\n19001021\xa0\n(중국) 2027-02-27\n제품화\n레디큐\n상표\n중문상표\n2017-02-28\n르어닝쿠(한자)(락저혹)\n19006964\xa0\n(중국) 2027-02-27\n제품화\n레디큐\n상표\n중문상표\n2017-03-07\n루이디쿠(한자)(서제혹)\n19001022\xa0\n\xa0(중국) 2027-03-06\n제품화\n레디큐\n상표\n국문/영문상표\n2017-04-25\nHANDOK 로고\n40-1248681\n(한국) 2027-04-25\n제품화\n사명\n상표\n국문/영문상표\n2017-04-25\nHANDOK 로고\n40-1248682\n(한국) 2027-04-25\n제품화\n사명\n상표\n영문상표\n2017-04-25\n한독 로고\n40-1248683\n(한국) 2027-04-25\n제품화\n사명\n상표\n영문상표\n2017-04-25\n한독 로고\n40-1248684\n(한국) 2027-04-25\n제품화\n사명\n상표\n중문상표\n2017-04-28\n루이디쿠(한자)(서제혹)\n19392980\n(중국) 2027-04-27\n제품화\n레디큐\n상표\n중문상표\n2017-04-28\n르어닝쿠(한자)(락저혹)\n19392981\xa0\n(중국) 2027-04-27\n제품화\n레디큐\n상표\n영문상표\n2017-05-12\nHANDOK\n40-1252338\n(한국) 2027-05-12\n제품화\n사명\n상표\n영문상표\n2017-06-02\nHANDOK\n40-1257706\n(한국) 2027-06-02\n제품화\n사명\n상표\n도형상표\n2017-06-20\n도형상표(2017.06.20)\n40-1262202\n(한국) 2027-06-20\n제품화\n레디큐\n상표\n중문상표\n2017-06-28\n한도\n19921955\xa0\n(중국) 2027-06-27\n제품화\n사명\n상표\n중문상표\n2017-06-28\n한도\n19922788\xa0\n(중국) 2027-06-27\n제품화\n사명\n상표\n중문상표\n2017-06-28\n한도\n19922574\xa0\n(중국) 2027-06-27\n제품화\n사명\n상표\n중문상표\n2017-06-28\n한도\n19922595\xa0\n(중국) 2027-06-27\n제품화\n사명\n상표\n중문상표\n2017-06-28\n한도\n19922465\xa0\n(중국) 2027-06-27\n제품화\n사명\n상표\n중문상표\n2017-06-28\n한도\n19922254\xa0\n(중국) 2027-06-27\n제품화\n사명\n상표\n중문상표\n2017-06-28\n한덕\n19921948\xa0\n(중국) 2027-06-27\n제품화\n사명\n상표\n중문상표\n2017-06-28\n한덕\n19922660\xa0\n(중국) 2027-06-27\n제품화\n사명\n상표\n중문상표\n2017-06-28\n한덕\n19922544\xa0\n(중국) 2027-06-27\n제품화\n사명\n상표\n중문상표\n2017-06-28\n한덕\n19922453\xa0\n(중국) 2027-06-27\n제품화\n사명\n상표\n중문상표\n2017-06-28\n한덕\n19922318\xa0\n(중국) 2027-06-27\n제품화\n사명\n상표\n중문상표\n2017-06-28\n한덕\n19922302\xa0\n(중국) 2027-06-27\n제품화\n사명\n상표\n영문상표\n2017-08-24\nReady Q\n40-1279652\n(한국) 2027-08-24\n제품화\n레디큐\n상표\n국문상표\n2017-10-01\n레디-큐\n1873143\xa0\n(대만) 2027-09-30\n제품화\n레디큐\n상표\n국문상표\n2017-10-24\n테라큐민\n40-1296993\n(한국) 2027-10-24\n제품화\n테라큐민\n상표\n영문상표\n2017-11-17\nKETOTOP\n2017/33692\n(남아프리카공화국) 2027-11-17\n제품화\n케토톱\n상표\n영문상표\n2018-01-05\nReadyQ\n6009383\xa0\n(일본) 2028-01-05\n제품화\n레디큐\n상표\n일문상표\n2018-01-05\n2018 01 05\n6009384\xa0\n(일본) 2028-01-05\n제품화\n레디큐\n상표\n국문상표\n2018-01-14\n케토톱\n22066200\xa0\n(중국) 2028-01-13\n제품화\n케토톱\n상표\n영문상표\n2018-01-14\nKETOTOP\n22066199\xa0\n(중국) 2028-01-13\n제품화\n케토톱\n상표\n중문상표\n2018-01-14\n2018 01 14\n22013439\n(중국) 2028-01-13\n제품화\n조아튼튼\n상표\n중문상표\n2018-01-14\n2018 01 14\n22013534\n(중국) 2028-01-13\n제품화\n조아튼튼\n상표\n영문상표\n2018-01-19\nTheracurmin\n40-1323404\n(한국) 2028-01-19\n제품화\n테라큐민\n상표\n영문상표\n2018-01-31\nHANDOK\n1399034\n(러시아) 2028-01-31\n제품화\n사명\n상표\n영문상표\n2018-01-31\nHANDOK\n1399034\n(미국) 2028-01-31\n제품화\n사명\n상표\n영문상표\n2018-01-31\nHANDOK\n1399034\n(싱가포르) 2028-01-31\n제품화\n사명\n상표\n영문상표\n2018-01-31\nHANDOK\n1399034\n(인도) 2028-01-31\n제품화\n사명\n상표\n영문상표\n2018-01-31\nHANDOK\n1399034\n(카자흐스탄) 2028-01-31\n제품화\n사명\n상표\n영문상표\n2018-01-31\nHANDOK\n1399034\n(캄보디아) 2028-01-31\n제품화\n사명\n상표\n영문상표\n2018-01-31\nHANDOK\n1399034\n(필리핀) 2028-01-31\n제품화\n사명\n상표\n영문상표\n2018-01-31\nHANDOK\n1399034\n(라오스) 2028-01-31\n제품화\n사명\n상표\n영문상표\n2018-01-31\nHANDOK\n1399034\n(호주) 2028-01-31\n제품화\n사명\n상표\n국문상표\n2018-02-21\n레디큐\n22768002\n(중국) 2028-02-20\n제품화\n레디큐\n상표\n국문상표\n2018-02-21\n레디큐\n22768080\n(중국) 2028-02-20\n제품화\n레디큐\n상표\n국문상표\n2018-02-21\n레디큐\n22767836\n(중국) 2028-02-20\n제품화\n레디큐\n상표\n영문상표\n2018-02-26\nKETOTOP\n1852579\n(멕시코) 2027-11-10\n제품화\n케토톱\n상표\n영문상표\n2018-02-28\nHANDOK\n304444939\xa0\n(홍콩) 2028-02-27\n제품화\n사명\n상표\n영문상표\n2018-03-03\n영문상표(2018.03.03)\n49604\n(브루나이) 2028-03-03\n제품화\n레디큐\n상표\n영문상표\n2018-03-20\nKETOTOP\n304329388\n(홍콩) 2028-03-20\n제품화\n케토톱\n상표\n도형상표\n2018-03-21\n레디큐 18 03 21\n16935498\n(중국) 2028-03-20\n제품화\n레디큐\n상표\n도형상표\n2018-03-28\n도형상표1(2018.03.28)\n4-2018-00004756\n(필리핀) 2028-11-29\n제품화\n레디큐\n상표\n도형상표\n2018-03-28\n도형상표2(2018.03.28)\n4-2018-00004755\n(필리핀) 2028-11-29\n제품화\n레디큐\n상표\n영문상표\n2018-03-28\nKETOTOP\n1439009331\n(사우디아라비아) 2027-09-19\n제품화\n케토톱\n상표\n영문상표\n2018-04-20\nKETOTOP\n2017/110195\n(터키) 2027-12-04\n제품화\n케토톱\n상표\n영문상표\n2018-04-24\nTheracurmin\n40-1353567\n(한국) 2028-04-24\n제품화\n테라큐민\n상표\n국문상표\n2018-07-13\n프로-업\n40-1377926\n(한국) 2028-07-13\n-\n-\n상표\n영문상표\n2018-07-13\nPro-Up\n40-1377927\n(한국) 2028-07-13\n-\n-\n상표\n영문상표\n2018-08-07\nReadyQ\n5532753\n(미국) 2028-08-07\n제품화\n레디큐\n상표\xa0\n영문상표\n2018-08-30\nHANDOK\n1399034\n(뉴질랜드) 2028-01-31\n제품화\n사명\n상표\n영문상표\n2018-10-22\nHANDOK\n40-1409036\n(한국) 2028-10-22\n제품화\n사명\n상표\n영문상표\n2018-10-22\nHANDOK\n40-1409037\n(한국) 2028-10-22\n제품화\n사명\n상표\n영문상표\n2018-10-22\nHANDOK\n40-1409038\n(한국) 2028-10-22\n제품화\n사명\n상표\n영문상표\n2018-11-07\n영문상표(2018.11.07)\n680522\n(러시아) 2028-03-07\n제품화\n레디큐\n상표\n영문상표\n2018-11-07\nHANDOK\n40-1414549\n(한국) 2028-11-07\n제품화\n사명\n상표\n국문상표\n2018-11-27\n기억다방\n40-1420833\n(한국) 2028-11-27\n-\n\u3000-\n상표\n국문상표\n2018-11-27\n기억다방\n40-1420834\n(한국) 2028-11-27\n-\n\u3000-\n상표\n국문상표\n2018-11-27\n기억다방\n40-1420835\n(한국) 2028-11-27\n-\n\u3000-\n상표\n국문상표\n2018-11-27\n기억다방\n40-1420836\n(한국) 2028-11-27\n-\n\u3000-\n상표\n국문상표\n2018-11-27\n훼스티아제\n40-1420838\n(한국) 2028-11-27\n-\n\u3000-\n상표\n국문상표\n2018-11-27\n훼스타젠\n40-1420837\n(한국) 2028-11-27\n-\n\u3000-\n상표\n영문상표\n2018-11-28\n영문상표(2018.11.28)\n27736908\xa0\n(중국) 2028-11-27\n제품화\n사명\n상표\n영문상표\n2018-11-28\n영문상표(2018.11.28)\n27736905\xa0\n(중국) 2028-11-27\n제품화\n사명\n상표\n영문상표\n2018-11-28\nHANDOK\n40-1421105\n(한국) 2028-11-28\n제품화\n사명\n상표\n국문상표\n2018-11-28\n훼스테제\n40-1421266\n(한국) 2028-11-28\n-\n\u3000-\n상표\n국문상표\n2018-11-28\n뉴훼스타제\n40-1421267\n(한국) 2028-11-28\n-\n\u3000-\n상표\n영문상표\n2018-12-18\nReadyQ\n1910625\n(호주) 2028-03-01\n제품화\n레디큐\n상표\n국문상표\n2018-12-20\n한독제석재단\n40-1429069\n(한국) 2028-12-20\n-\n-\n상표\n국문상표\n2019-01-11\n뉴페스타\n40-1436076\n(한국) 2029-01-11\n-\n-\n상표\n국문상표\n2019-01-11\n뉴휘스탈\n40-1436077\n(한국) 2029-01-11\n-\n-\n상표\n영문상표\n2019-01-24\n영문상표(2019.01.24)\n693955\n(러시아) 2028-03-07\n제품화\n레디큐\n상표\n영문상표\n2019-01-30\nReadyQ\n1910626\n(호주) 2028-03-01\n제품화\n레디큐\n상표\n영문상표\n2019-02-05\nKETOTOP\n913813150\xa0\n(브라질) 2029-02-05\n제품화\n케토톱\n상표\n도형상표\n2019-02-07\n도형상표(2019.02.07)\n19480390\xa0\n(중국) 2029-02-06\n제품화\n레디큐\n상표\n영문상표\n2019-02-11\nKETOTOP\n42449\xa0\n(라오스) 2028-01-15\n제품화\n케토톱\n상표\n영문상표\n2019-03-01\nReady Q\n1087911\xa0\n(뉴질랜드) 2028-03-31\n제품화\n레디큐\n상표\n도형상표\n2019-03-01\n도형상표(2019.03.01)\n1974150\n(대만) 2029-02-28\n제품화\n레디큐\n상표\n영문상표\n2019-03-01\nReady Q\n1974756\xa0\n(대만) 2029-02-28\n제품화\n레디큐\n상표\n도형상표\n2019-03-01\n도형상표(2019.03.01)\n1973906\n(대만) 2029-02-28\n제품화\n레디큐\n상표\n영문상표\n2019-03-07\n영문상표(2019.03.07)\n27736907\xa0\n(중국) 2029-03-06\n제품화\n사명\n상표\n국문상표\n2019-03-12\n뉴수탈\n40-1456965\n(한국) 2029-03-12\n-\n-\n상표\n국문상표\n2019-03-12\n윈스탈\n40-1456966\n(한국) 2029-03-12\n-\n-\n상표\n국문상표\n2019-03-12\n윈수탈\n40-1456967\n(한국) 2029-03-12\n-\n-\n상표\n국문상표\n2019-03-12\n한스탈\n40-1456968\n(한국) 2029-03-12\n-\n-\n상표\n국문상표\n2019-03-25\n기억다방\n40-1461700\n(한국) 2029-03-25\n-\n-\n상표\n국문상표\n2019-03-25\n기억다방\n40-1461701\n(한국) 2029-03-25\n-\n-\n상표\n국문상표\n2019-03-25\n기억다방\n40-1461702\n(한국) 2029-03-25\n-\n-\n상표\n영문상표\n2019-05-09\nKETOTOP\n158220\n(요르단) 2028-01-21\n제품화\n케토톱\n상표\n영문상표\n2019-05-20\nKETOTOP\n1014760\xa0\n(알제리) 2027-12-03\n제품화\n케토톱\n상표\n도형상표\n2019-05-28\n도형상표(2019.05.28)\n16935499\n(중국) 2029-05-27\n제품화\n레디큐\n상표\n영문상표\n2019-05-28\nReady Q\n16935496\n(중국) 2029-05-27\n제품화\n레디큐\n상표\n영문상표\n2019-06-01\nHANDOK\n1991265\xa0\n(대만) 2029-05-31\n제품화\n사명\n상표\n영문상표\n2019-07-07\nReady Q\n16935497\xa0\n(중국) 2029-07-06\n제품화\n레디큐\n상표\n영문상표\n2019-07-08\nHOESTAZEN 훼스타젠\n40-1497559\n(한국) 2029-07-08\n\u3000-\n\u3000-\n상표\n영문상표\n2019-07-10\nHANDOK\n1399034\n(일본) 2028-01-31\n제품화\n사명\n상표\n영문상표\n2019-07-17\nNEWHOESTAZE 뉴훼스타제\n40-1500950\n(한국) 2029-07-17\n\u3000-\n\u3000-\n상표\n영문상표\n2019-07-17\nHOESTEZE\n40-1500951\n(한국) 2029-07-17\n\u3000-\n\u3000-\n상표\n영문상표\n2019-07-17\nHOESTIAZE 훼스티아제\n\xa040-1500949\xa0\n(한국) 2029-07-17\n\u3000-\n\u3000-\n상표\n영문상표\n2019-07-17\nKETOTOP\n49479\xa0\n(브루나이) 2028-01-11\n제품화\n케토톱\n상표\n영문상표\n2019-07-18\nKETOTOP\nRTM 15387\n(나이지리아) 2024-11-20\n제품화\n케토톱\n상표\n영문상표\n2019-11-25\nKETOTOP\n191122250\xa0\n(태국) 2028-01-16\n제품화\n케토톱\n상표\n국문상표\n2019-12-11\n뉴스탈\n40-152777\n(한국) 2029-12-11\n-\n-\n상표\n영문상표\n2020-02-06\nKETOTOP\n67364\xa0\n(카자흐스탄) 2029-04-23\n제품화\n케토톱\n상표\n중문상표\n2020-04-01\n2020.04.01\n2049651\xa0\n(대만) 2030-03-31\n-\n-\n상표\n중문상표\n2020-04-01\n2020.04.01\n2049652\xa0\n(대만) 2030-03-31\n-\n-\n상표\n중문상표\n2020-04-01\n科泰貼(커타이티에)\n2049653\xa0\n(대만) 2030-03-31\n-\n-\n상표\n중문상표\n2020-04-01\n掘他痛(쥬에타통)\n2049654\xa0\n(대만) 2030-03-31\n-\n-\n상표\n영문상표\n2020-05-13\nREADY Q\nIDM000705878\n(인도네시아) 2028-03-26\n제품화\n레디큐\n상표\n영문상표\n2020-05-13\nREADY Q\n\xa0IDM000705880\n(인도네시아) 2028-03-26\n제품화\n레디큐\n상표\n중문상표\n2020-06-01\n刻脫痛(커터우통)\n2061652\xa0\n(대만) 2030-05-31\n-\n-\n상표\n영문상표\n2020-06-08\nKETOTOP\nKH/76484/20 \xa0\n(캄보디아) 2027-12-12\n제품화\n케토톱\n상표\n영문상표\n2020-06-23\nHANDOK KETOTOP\nKH/76697/20\n(캄보디아) 2029-01-23\n제품화\n케토톱\n상표\n영문상표\n2020-08-13\nREADYQ\n359563\xa0\n(베트남) 2025-01-12\n제품화\n레디큐\n상표\n영문상표\n2021-01-04\nKETOTOP\n40-1677899\n(한국) 2031-01-03\n제품화\n케토톱\n상표\n영문상표\n2021-01-21\nCLEARTEEN\n46211974\xa0\n(중국) 2031-01-20\n제품화\n클리어틴\n상표\n국문상표\n2021-01-21\n클리어틴\n46211973\xa0\n(중국) 2031-01-20\n제품화\n클리어틴\n상표\n국문상표\n2021-02-19\n일상건강\n40-1694757\n(한국) 2031-02-19\n제품화\n온라인몰\n상표\n국문상표\n2021-02-19\n일상건강\n40-1694758\n(한국) 2031-02-19\n제품화\n온라인몰\n상표\n국문상표\n2021-02-19\n일상건강\n40-1694759\n(한국) 2031-02-19\n제품화\n온라인몰\n상표\n국문상표\n2021-02-19\n일상건강\n40-1694760\n(한국) 2031-02-19\n제품화\n온라인몰\n상표\n국문상표\n2021-02-19\n일상건강\n40-1694761\n(한국) 2031-02-19\n제품화\n온라인몰\n상표\n영문상표\n2021-04-06\nKETOTOP\n3.158.753\n(아르헨티나) 2031-04-06\n제품화\n케토톱\n상표\n국문상표\n2021-04-13\n한독\n40-1715347\n(한국) 2031-04-13\n제품화\n사명\n상표\n영문상표\n2021-04-13\nHANDOK\n40-1715346\n(한국) 2031-04-13\n제품화\n사명\n상표\n국문상표\n2021-05-11\n페스타젠\n40-1726342\n(한국) 2031-05-11\n-\n-\n상표\n영문상표\n2021-06-27\nREADYQ\n3764797\xa0\n(인도) 2028-02-26\n제품화\n레디큐\n상표\n국문상표\n2021-07-19\n한독 소화엔\xa0\n40-1753996\n(한국) 2031-07-19\n-\n-\n상표\n국문상표\n2021-07-19\n한독 슈퍼자임\n40-1753997\n(한국) 2031-07-19\n-\n-\n상표\n국문상표\n2021-07-19\n속편정\n\xa040-1753998\xa0\n(한국) 2031-07-19\n-\n-\n상표\n영문상표\n2021-04-16\nHANDOK\n4/2021/00501813\n(필리핀) 2031-04-16\n제품화\n사명\n상표\n영문상표\n2021-06-04\nKETOTOP\n4/2021/00504693\n(필리핀) 2031-06-04\n제품화\n케토톱\n상표\n영문상표\n2022-02-17\n영문상표(2022.02.17)\n2018002781\n(말레이시아) 2028-03-11\n제품화\n레디큐\n상표\n영문상표\n2022-02-17\n영문상표(2022.02.17)\n2018002782\n(말레이시아) 2028-03-11\n제품화\n레디큐\n디자인\n디자인\n2010-06-23\n알약\n30-0565518\n(한국) 2025-06-23\n제품화\n아마릴\n디자인\n디자인\n2014-02-06\n롤파스 케이스\n30-0729101\n(한국) 2029-02-06.\n제품화\n롤파스\n디자인\n디자인\n2015-03-31\n알약\n30-0791059\n(한국) 2030-03-31.\n제품화\n싸이타민\n디자인\n디자인\n2015-06-08\n알약인형\n30-0800961\n(한국) 2034-12-15.\n제품화\n외부조형물\n디자인\n디자인\n2016-07-27\n알약인형\n30-0808581\n(한국) 2034-12-15.\n제품화\n외부조형물\n']"
